Printer Friendly

MEDIMMUNE SELLS 2.5 MILLION SHARES OF COMMON STOCK

 MEDIMMUNE SELLS 2.5 MILLION SHARES OF COMMON STOCK
 GAITHERSBURG, Md., Dec. 10 /PRNewswire/ -- MedImmune, Inc.


(NASDAQ: MEDI) announced that it has sold 2.5 million shares of common stock priced at $43.50 per share. Of the shares offered, 500,000 shares were sold by the company and 2.0 million shares were sold by selling shareholders. The underwriters for this offering are Morgan Stanley & Co. Incorporated and Smith Barney, Harris Upham & Co. Incorporated. After the offering, MedImmune will have 16.9 million shares of common stock outstanding on a fully diluted basis, prior to any shares sold to cover over-allotments.
 MedImmune, Inc. was founded in 1988 to develop, manufacture and market therapeutics and vaccines for the treatment and prevention of certain infectious diseases and cancers.
 Copies of the prospectus can be obtained from the office of Morgan Stanley & Co. Incorporated, 1251 Avenue of the Americas, New York, N.Y. 10020, or Smith Barney, Harris Upham & Co. Incorporated, 1345 Avenue of the Americas, New York, N.Y. 10105.
 -0- 12/10/91
 /CONTACT: Emilio O. DiCataldo, senior vice president of MedImmune, 301-417-0770, Fred Spar of Kekst and Company, 212-593-2655, for MedImmune/
 (MEDI) CO: MedImmune Inc. ST: Maryland IN: MTC SU: OFR SH -- NY014 -- 0888 12/10/91 09:37 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 10, 1991
Words:211
Previous Article:AFRICAN DEVELOPMENT BANK $200 MILLION SUBORDINATED DEBT RATED "AA+" -- FITCH FINANCIAL WIRE --
Next Article:PENTLAND GROUP PLC TO SELL HOLDING IN REEBOK INTERNATIONAL
Topics:


Related Articles
MEDIMMUNE FILES REGISTRATION STATEMENT FOR 2.0 MILLION SHARES OF COMMON STOCK
MEDIMMUNE SELLS 3.0 MILLION SHARES OF COMMON STOCK
MEDIMMUNE SELLS ADDITIONAL 450,000 SHARES IN OVER-ALLOTMENT OF PUBLIC OFFERING
MEDIMMUNE PLACES $60 MILLION IN 7 PERCENT CONVERTIBLE SUBORDINATED NOTES; TRANSACTION EXPECTED TO CLOSE JULY 8, 1996
MedImmune Adopts Stockholder Rights Plan
MedImmune Announces $66.3 Million Private Placement
MedImmune Closes $66.3 Million Private Placement
MedImmune Authorizes New $500 Million Stock Repurchase Program.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters